Michael Harty (Clare, Independent) | Oireachtas source

I will ask one more question before we wind up. What criteria will be used to approve products? How will the HPRA go about approving products that will be used in the access programme? A product that suits one illness might not suit another in terms of the combination of CBD and THC. How will the HPRA adjudicate on this matter?